Previous 10 | Next 10 |
2023-03-07 12:10:00 ET Vancouver, Kelowna, Delta, BC - March 7, 2023 (Investorideas.com Newswire) Investorideas.com , a global investor news source covering Artificial Intelligence (AI) brings you today's edition of The AI Eye; - watching stock news, deal tracker and advancements in...
Nevro Announces U.S. Full Market Launch of Revolutionary HFX iQ™ Spinal Cord Stimulation System to Personalize Treatment of Chronic Pain PR Newswire Senza® HFX iQ™ is the First and Only SCS System that Uses Artificial Intelligence to Optimize and Maintain ...
TORONTO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold Global” or the “Company”), a Clean Technology Company accelerating the world’s transition to a circular-resource economy, announces that it pr...
Nevro to Participate in Wells Fargo 2023 Medtech Innovation Spotlight Call Series PR Newswire Friday, March 24, 2023 at 2:00 pm Eastern Time REDWOOD CITY, Calif. , Feb. 23, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device...
Medical device company Nevro ( NYSE: NVRO ) hit a 52-week low of $33.36 on Wednesday afternoon. Over the last year, the stock is down ~49% . In 2022, the company, known for its Senza spinal cord stimulation system, a neuromodulation platform for chronic pain, saw its revenue incre...
Nevro Corporation (NVRO) Q4 2022 Earnings Conference Call February 16, 2023 4:30 PM ET Company Participants Julie Dewey - Chief Corporate Communications and Investor Relations Officer Keith Grossman - Chairman, CEO and President Rod MacLeod - Chief Financial Officer ...
Nevro press release ( NYSE: NVRO ): Q4 GAAP EPS of -$0.54 misses by $0.05 . Revenue of $113.84M (+10.8% Y/Y) beats by $0.14M . Provides First Quarter 2023 Revenue Guidance of $94 Million to $96 Million Representing 9% to 11% Constant Currency Growth; Reiterates Full-Ye...
Nevro Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides First Quarter and Complete Full-Year 2023 Guidance PR Newswire REDWOOD CITY, Calif. , Feb. 16, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is ...
Summary Nevro Corp. has seen multiple boom-bust cycles in its share price, and we are in the bust phase again. Unlike previous times, the Nevro Corp. growth story has been impaired, with revenues stable for a while now. Sales multiples look reasonable, but lack of growth and large l...
Summary Cryoport has significantly underperformed the broader market over the past several months, largely due to poor earnings and cash flows. The company has excess cash on its books, but this doesn't make it a great prospect when you consider its continued profitability issues. A...
News, Short Squeeze, Breakout and More Instantly...
Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024 PR Newswire REDWOOD CITY, Calif. , July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-chan...
Nevro to Present at Truist Securities MedTech Conference PR Newswire REDWOOD CITY, Calif. , June 11 , 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chr...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif. , May 24, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the trea...